MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurose, K.
Right arrow Articles by Fukuhara, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurose, K.
Right arrow Articles by Fukuhara, M.

Vol. 55, Issue 2, 279-287, February 1999

A Novel Positive Regulatory Element That Enhances Hamster CYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element

Kouichi Kurose, Masahiro Tohkin, and Morio Fukuhara

Department of Pharmaceutical Sciences, National Institute of Public Health, Minato-ku, Tokyo, Japan

CYP2A8 is a major form of cytochrome P-450 inducible by 3-methylcholanthrene in Syrian hamster liver. To identify DNA elements necessary for the transcriptional activation of the CYP2A8 gene, we analyzed the regulatory region of the CYP2A8 gene and conducted transient transfection experiments of CYP2A8-luciferase fusion plasmids in primary cultures of hamster hepatocytes. We analyzed up to -5 kb of the 5'-flanking region and found the region sufficient for the 3-methylcholanthrene-inducible gene expression. This region contained a consensus sequence for xenobiotic responsive element (XRE) between -2366 and -2349, which was shown to be essential for induction of the gene expression. Furthermore, we found a novel positive regulatory element for XRE-mediated gene expression (PREX) located upstream of the XRE. This element is not identified in any genes inducible by 3-methylcholanthrene so far reported. Without PREX, the XRE-mediated promoter activity was enhanced nearly 10-fold, whereas with PREX, the activity was enhanced 20-fold over the basal level. Gel mobility shift assays revealed specific binding of nuclear proteins to PREX. Mutations and deletions of PREX caused a loss of the binding and promoter-enhancing activities, respectively. Moreover, transient expression experiments showed that the enhancing activity of PREX was not observed in Drosophila Schneider's line 2 cells, which were shown to lack the PREX binding proteins.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
S. Arpiainen, F. Raffalli-Mathieu, M. A. Lang, O. Pelkonen, and J. Hakkola
Regulation of the Cyp2a5 Gene Involves an Aryl Hydrocarbon Receptor-Dependent Pathway
Mol. Pharmacol., April 1, 2005; 67(4): 1325 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. P. Rivera, S. T. Saarikoski, and O. Hankinson
Identification of a Novel Dioxin-Inducible Cytochrome P450
Mol. Pharmacol., February 1, 2002; 61(2): 255 - 259.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Tohkin, M. Fukuhara, G. Elizondo, S. Tomita, and F. J. Gonzalez
Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A
Mol. Pharmacol., October 1, 2000; 58(4): 845 - 851.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics